Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Reozalimab

Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research[1][2].

Product Specifications

CAS Number

[2445259-99-2]

Product Name Alternative

LY3434172

UNSPSC

12352203

Target

PD-1/PD-L1

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/reozalimab.html

Purity

99.90

Solubility

10 mM in DMSO|H2O

Smiles

[Reozalimab]

Molecular Weight

(143.55 kDa)

References & Citations

[1]Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12.|[2]Reozalimab. IMGT/mAb-DB.

Shipping Conditions

Dry Ice

Storage Conditions

Store at -80°C for 2 years

Scientific Category

Inhibitory Antibodies

Clinical Information

Phase 1

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Collagen IV (COL4A2) (NM_001846) Human Over-expression Lysate
LH05890V 100 µg

Collagen IV (COL4A2) (NM_001846) Human Over-expression Lysate

Ask
View Details
pCMV-SPORT6-ARL6IP5 Plasmid
PVT31308 2 µg

pCMV-SPORT6-ARL6IP5 Plasmid

Ask
View Details
GANAB antibody - middle region
MBS3212443-01 0.1 mL

GANAB antibody - middle region

Ask
View Details
GANAB antibody - middle region
MBS3212443-02 5x 0.1 mL

GANAB antibody - middle region

Ask
View Details
Monobenzone
C07956-01 5 mg

Monobenzone

Ask
View Details
Monobenzone
C07956-02 50 mg

Monobenzone

Ask
View Details